Cargando…

Correction: Type I Interferon: Potential Therapeutic Target for Psoriasis?

Detalles Bibliográficos
Autores principales:	Yao, Yihong, Richman, Laura, Morehouse, Chris, de los Reyes, Melissa, Higgs, Brandon W., Boutrin, Anmarie, White, Barbara, Coyle, Anthony, Krueger, James, Kiener, Peter A., Jallal, Bahija
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2665006/ http://dx.doi.org/10.1371/annotation/fbcbcab9-2e87-4ec7-af6e-c6e9e64ad4b3

Ejemplares similares

Type I Interferon: Potential Therapeutic Target for Psoriasis?
por: Yao, Yihong, et al.
Publicado: (2008)

Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus
por: Yao, Yihong, et al.
Publicado: (2009)

Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNα antibody, in systemic lupus erythematosus
por: Yao, Yihong, et al.
Publicado: (2010)

Altered Expression of Insulin Receptor Isoforms in Breast Cancer
por: Huang, Jiaqi, et al.
Publicado: (2011)

Genomic signatures characterize leukocyte infiltration in myositis muscles
por: Zhu, Wei, et al.
Publicado: (2012)

A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
por: Higgs, Brandon W, et al.
Publicado: (2014)

Developing innovative targeted therapies for China
por: Jallal, Bahija
Publicado: (2012)

microRNA-mediated regulation of innate immune response in rheumatic diseases
por: Luo, Xiaobing, et al.
Publicado: (2013)

Correction: Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris
por: Bissonnette, Robert, et al.
Publicado: (2016)

Suppression of soluble T cell-associated proteins by an anti-interferon-α monoclonal antibody in adult patients with dermatomyositis or polymyositis
por: Guo, Xiang, et al.
Publicado: (2014)

Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases
por: Wong, David, et al.
Publicado: (2012)

Author Correction: Up-regulation of Interferon-inducible protein 16 contributes to psoriasis by modulating chemokine production in keratinocytes
por: Cao, Tianyu, et al.
Publicado: (2020)

Psoriasis and Hepatitis C: Improvement with Interferon
por: Habte-Gabr, Eyassu, et al.
Publicado: (2011)

Correction: Report of the inaugural Interferon Research Summit: interferon in inflammatory diseases
Publicado: (2018)

Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus
por: Riggs, Jeffrey M, et al.
Publicado: (2018)

Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinoma
por: Jiang, Liyan, et al.
Publicado: (2014)

Interferon Kappa Is Up-Regulated in Psoriasis and It Up-Regulates Psoriasis-Associated Cytokines in vivo
por: Li, Yuanyuan, et al.
Publicado: (2019)

Mi conejo /
por: Barrie Anmarie
Publicado: (2000)

Correction: Smoking as a Permissive Factor of Periodontal Disease in Psoriasis
Publicado: (2014)

Correction: Cost-of-Illness in Psoriasis: Comparing Inpatient and Outpatient Therapy
por: Steinke, Sabine, et al.
Publicado: (2014)

Correction to: Risankizumab: A Review in Moderate to Severe Plaque Psoriasis
por: Blair, Hannah A.
Publicado: (2020)

Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer
por: Jiang, Liyan, et al.
Publicado: (2016)

Role of interferon regulatory factor-mediated signaling in psoriasis
por: Wang, Wen-Ming, et al.
Publicado: (2021)

Correction: Value in psoriasis (IRIS) trial: implementing value-based healthcare in psoriasis management – a 1-year prospective clinical study to evaluate feasibility and value creation
Publicado: (2023)

Correction to: Transcriptomes of microglia in experimental cerebral malaria in mice in the presence and absence of Type I Interferon signaling
por: Talavera-López, Carlos, et al.
Publicado: (2019)

Correction to: Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs
por: Ghosh, Subrata, et al.
Publicado: (2019)

Correction to: Secukinumab: A Review in Moderate to Severe Pediatric Plaque Psoriasis
por: Blair, Hannah A.
Publicado: (2021)

Interferon γ is required for activation-induced death of T lymphocytes
por: Refaeli, Yosef, et al.
Publicado: (2012)

Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
por: Wagner, Steve, et al.
Publicado: (2019)

Correction: Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials
Publicado: (2016)

Correction to: Population Pharmacokinetics of Abrocitinib in Healthy Individuals and Patients with Psoriasis or Atopic Dermatitis
por: Wojciechowski, Jessica, et al.
Publicado: (2022)

Extensive psoriasis induced by pegylated interferon: a case report
por: Citro, Vincenzo, et al.
Publicado: (2007)

The Role of Plasmacytoid Dendritic Cells and Interferon-Alpha in the Immunopathogenesis of Psoriasis
por: Denadai, Rafael
Publicado: (2013)

Correction to: Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data
por: Dattola, Annunziata, et al.
Publicado: (2017)

Correction to: Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence
por: Wu, Jashin J., et al.
Publicado: (2020)

Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysis
por: Steele, Keith E., et al.
Publicado: (2018)

Glatiramer acetate treatment negatively regulates type I interferon signaling
Publicado: (2015)

Glial cells express nuclear Nrf2 after fumarate treatment for multiple sclerosis and psoriasis
Publicado: (2015)

Correction: A catalog of potential putative functional variants in psoriasis genome-wide association regions
por: Lin, Yan, et al.
Publicado: (2018)

Author Correction: Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis
por: Zuo, Xianbo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e50dj2eanp25rs378ulqef5ne2